The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2025 / Articles / Sept / Preparing for CPHI 2025 in Frankfurt
Industry News Sponsored

Preparing for CPHI 2025 in Frankfurt

Our interview with Tara Dougal offers a snapshot of what to expect at the event.

09/23/2025 0 min read

Sponsored By

Informa Markets

Share

Running from October 28 to 30 at Messe Frankfurt, Germany, CPHI Frankfurt is expected to draw more than 63,000 attendees. The event brings together professionals from across the drug development and manufacturing ecosystem, and will feature six content theaters, more than 2,000 exhibitors, and a packed program focusing on networking and innovation. New zones have also been introduced to spotlight topics such as digital health technologies, AI-powered drug development, and sustainable pharma manufacturing.

Learn more about the event in this interview with Tara Dougal, Event Director – Pharma at Informa Markets.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

This Week’s CGT News: In Vivo CAR T Draws Major Investment
Cell & Gene Industry News Research News
This Week’s CGT News: In Vivo CAR T Draws Major Investment

August 10, 2026

3 min read

Johnson & Johnson partners with Sail Biomedicines, an FDA advisory committee votes against deramiocel for Duchenne cardiomyopathy, and researchers uncover factors influencing CAR T and CAR NK outcomes

Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy
Cell & Gene Industry News Technology & Manufacturing
Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy

July 14, 2026

3 min read

VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies

FDA Selects Seven Companies for Drug Manufacturing Pilot
Industry News Regulation & Standards Biopharma
FDA Selects Seven Companies for Drug Manufacturing Pilot

July 13, 2026

2 min read

Selected companies will receive earlier FDA engagement to support new US drug manufacturing facilities across small molecules, biologics, sterile injectables, and advanced therapies

This Week's CGT News: World's First Solid Tumor CAR T Approved in China
Cell & Gene Industry News Research News
This Week's CGT News: World's First Solid Tumor CAR T Approved in China 

June 30, 2026

5 min read

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: